Abstract
Events following the attacks on New York City and Washington, DC on September 11, 2001, have served to underscore the need for extensive research on biological warfare (BW) and other agents in order to aid the initiative to fight terrorism worldwide. During the Cold War era, the former USSR covertly developed, tested, and stockpiled immense amounts of biological weapons in an effort to build the largest and most advanced biological warfare program in the world. The knowledge developed in these laboratories and manufacturing sites has since undoubtedly spread to other regimes and terrorist organizations. Research on these agents of bioterrorism concern is of highest priority to enhance diagnostic, preventative, and therapeutic measures. Pathogens that may be potentially adapted for biological warfare include those causing smallpox (Variola), anthrax (Bacillus anthracis), plague (Yersinia pestis), tularemia (Francisella tularensis), brucellosis (Brucella abortus, B. melitensis, B. suis, B. canis), Q fever (Coxiella burnetii), botulism (Clostridium botulinum), glanders (Burkholderia mallei), and enterotoxin B producing Staphylococcus spp. All of these agents constitute considerable threat to military personnel and civilians alike in the dreaded event of a bioterrorist affront.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Fleischmann, R. D., Adams, M. D., White, O., et al. (1995) Whole-genome random sequencing and assembly of Haemophilus influenzae Rd. Science 269, 496–512.
Salzberg, S. L., Delcher, A. L., Kasif, S., and White, O. (1998) Microbial gene identification using interpolated Markov models. Nucleic Acids Res. 26, 544–548.
Delcher, A. L., Harmon, D., Kasif, S., White, O., and Salzberg, S. L. (1999) Improved microbial gene identification with GLIMMER. Nucleic Acids Res. 27, 4636–4641.
Altschul, S. F., Gish, W., Miller, W., Myers, E. W., and Lipman, D. J. (1990) Basic local alignment search tool. J. Mol. Biol. 215, 403–410.
Bateman, A., Birney, E., Durbin, R., Eddy, S. R., Howe, K. L., and Sonnhammer, E. L. (2000) The Pfam protein families database. Nucleic Acids Res. 28, 263–266.
Haft, D. H., Loftus, B. J., Richardson, D. L., et al. (2001) TIGRFAMs: a protein family resource for the functional identification of proteins. Nucleic Acids Res. 29, 41–43.
Peterson, J. D., Umayam, L. A., Dickinson, T., Hickey, E. K., and White, O. (2001) The comprehensive microbial resource. Nucleic Acids Res. 29, 123–125.
Dixon, T. C., Meselson, M., Guillemin, J., and Hanna, P. C. (1999) Anthrax. N. Engl. J. Med. 341, 815–826.
Manchee, R. J., Broster, M. G., Anderson, I. S., Henstridge, R. M., and Melling, J. (1983) Decontamination of Bacillus anthracis on Gruinard Island? Nature 303, 239, 240.
Mock, M. and Fouet, A. (2001) Anthrax. Annu. Rev. Microbiol. 55, 647–71.
Hanna, P. C. and Ireland, J. A. (1999) Understanding Bacillus anthracis pathogenesis. Trends Microbiol. 7, 180–182.
Mikesell, P., Ivins, B. E., Ristroph, J. D., and Dreier, T. M. (1983) Evidence for plasmidmediated toxin production in Bacillus anthracis. Infect. Immun. 39, 371–376.
Pezard, C,. Berche, P., and Mock, M. (1991) Contribution of individual toxin components to virulence of Bacillus anthracis. Infect. Immun. 59, 3472–3477.
Green, B. D., Battisti, L., Koehler, T. M., Thorne, C. B., and Ivins, B. E. (1985) Demonstration of a capsule plasmid in Bacillus anthracis. Infect. Immun. 49, 291–297.
Uchida, I., Sekizaki, T., Hashimoto, K., and Terakado, N. (1985) Association of the encapsulation of Bacillus anthracis with a 60 megadalton plasmid. J. Gen. Microbiol. 131(Pt. 2), 363–367.
Little, S. F. and Knudson, G. B. (1986) Comparative efficacy of Bacillus anthracis live spore vaccine and protective antigen vaccine against anthrax in the guinea pig. Infect. Immun. 52, 509–512.
Read, T. D., et al. (2003) The genome sequence of Bacillus anthracis AMES and comparison to closely related bacteria. Nature 423(6935), 81–86.
Okinaka, R., Cloud, K., Hampton, O., et al. (1999) Sequence, assembly and analysis of pX01 and pX02. J. Appl. Microbiol. 87, 261, 262.
Okinaka, R. T., Cloud, K., Hampton, O., et al. (1999) Sequence and organization of pXO1, the large Bacillus anthracis plasmid harboring the anthrax toxin genes. J. Bacteriol. 181, 6509–6515.
Thorne, C. B. (1993) Bacillus anthracis, in Bacillus subtilis and Other Gram-Positive Bacteria. American Society for Microbiology, Washington, DC, pp. 113-124.
Keim, P., Price, L. B., Klevytska, A. M., et al. (2000) Multiple-locus variable-number tandem repeat analysis reveals genetic relationships within Bacillus anthracis. J. Bacteriol. 182, 2928–2936.
Read, T. D., Salzberg, S. L., Pop, M., et al. (2002) Comparative genome sequencing for discovery of novel polymorphisms in Bacillus anthracis. Science 9, 9.
Baca, O. G. and Paretsky, D. (1983) Q fever and Coxiella burnetii: a model for hostparasite interactions. Microbiol. Rev. 47, 127–149.
Broqui, P., Dupont, H. T., Drancourt, M., et al. (1993) Chronic Q fever. Arch. Int. Med. 153, 642–648.
Babudieri, C. (1959) Q fever: a zoonosis. Adv. Vet. Sci. 5, 81–84.
Weisburg, W. G., Dobson, M. E., Samuel, J. E., et al. (1989) Phylogenetic diversity of the Rickettsiae. J. Bacteriol. 171, 4202–4206.
Reiner, N. E. (1994) Altered cell signaling and mononuclear phagocyte deactivation during intracellular infection. Immunol. Today 15, 374–381.
Wiebe, M. E., Burton, P. R., and Shankel, D. M. (1972) Isolation and characterization of two cell types of Coxiella burnetii phase I. J. Bacteriol. 110, 368–377.
Williams, J. C., Johnston, M. R., Peacock, M. G., Thomas, L. A., Stewart, S., and Portis, J. L. (1984) Monoclonal antibodies distinguish phase variants of Coxiella burnetii. Infect. Immun. 43, 421–428.
Seshadri, R., et al. (2003) Complete genome sequence of the Q-fever pathogen Coxiella burnetii. Proc. Natl. Acad. Sci. USA 100(9), 5455–5460.
Ogata, H., Audic, S., Renesto-Audiffren, P., et al. (2001) Mechanisms of evolution in Rickettsia conorii and R. prowazekii. Science 293, 2093–2098.
Afseth, G., Mo, Y. Y., and Mallavia, L. P. (1995) Characterization of the 23S and 5S rRNA genes of Coxiella burnetii and identification of an intervening sequence within the 23S rRNA gene. J. Bacteriol. 177, 2946–2949.
Tettelin, H., Saunders, N. J., Heidelberg, J., et al. (2000) Complete genome sequence of Neisseria meningitidis serogroup B strain MC58. Science 287, 1809–1815.
Nicoletti, P. (1980) The epidemiology of bovine brucellosis. Adv. Vet. Sci. Comp. Med. 24, 69–98.
Roux, J. (1979) [Epidemiology and prevention of brucellosis]. Bull. World Health Org. 57, 179–194.
Young, E. J. (1988) Brucellosis: a model zoonosis in developing countries. APMIS Suppl. 3, 17–20.
Young, E. J. (1995) An overview of human brucellosis. Clin. Infect. Dis. 21, 283–289; quiz 290.
Hall, W. H. (1990) Modern chemotherapy for brucellosis in humans. Rev. Infect. Dis. 12, 1060–1099.
Young, E. J. (1983) Human brucellosis. Rev. Infect. Dis. 5, 821–842.
Hoover, D. L., Crawford, R. M., Van De Verg, L. L., et al. (1999) Protection of mice against brucellosis by vaccination with Brucella melitensis WR201(16MDeltapurEK). Infect. Immun. 67, 5877–5884.
Detilleux, P. G., Deyoe, B. L., and Cheville, N. F. (1990) Penetration and intracellular growth of Brucella abortus in nonphagocytic cells in vitro. Infect. Immun. 58, 2320–2328.
Detilleux, P. G., Deyoe, B. L., and Cheville, N. F. (1990) Entry and intracellular localization of Brucella spp. in Vero cells: fluorescence and electron microscopy. Vet. Pathol. 27, 317–328.
DelVecchio, V. G., Kapatral, V., Redkar, R. J., et al. (2002) The genome sequence of the facultative intracellular pathogen Brucella melitensis. Proc. Natl. Acad. Sci. USA 99, 443–448.
Paulsen, I. T., et al. (2002) The Brucella suis genome reveals fundamental similarities between animal and plant pathogens and symbiants. Proc. Natl. Acad. Sci. USA 99(20), 13,148–13,153.
McGilvray, C. D. (1944) The transmission of glanders from horse to man. Can. J. Public Health 35, 268–275.
Stanton, A. T. and Fletcher, W. (1925) Melidosis and its relation to glanders. J. Hyg. 23, 347–363.
Neubauer, H., Meyer, H., and Finke, E. J. (1997) Human glanders. Revue Internationale Des Services De Sante Des Forces Armees 70, 258–265.
Rood, J. I. and Cole, S. T. (1991) Molecular genetics and pathogenesis of Clostridium perfringens. Microbiol. Rev. 55, 621–648.
Williamson, E. D. and Titball, R. W. (1993) A genetically engineered vaccine against the alpha-toxin of Clostridium perfringens protects mice against experimental gas gangrene. Vaccine 11, 1253–1258.
O’Brien, D. K. and Melville, S. B. (2000) The anaerobic pathogen Clostridium perfringens can escape the phagosome of macrophages under aerobic conditions. Cell. Microbiol. 2, 505–519.
Stevens, D. L., Tweten, R. K., Awad, M. M., Rood, J. I., and Bryant, A. E. (1997) Clostridial gas gangrene: evidence that alpha and theta toxins differentially modulate the immune response and induce acute tissue necrosis. J. Infect. Dis. 176, 189–195.
Netherwood, T., Chanter, N., and Mumford, J. A. (1996) Improved isolation of Clostridium perfringens from foal faeces. Res. Vet. Sci. 61, 147–151.
Shimizu, T., Ohtani, K., Hirakawa, H., et al. (2002) Complete genome sequence of Clostridium perfringens, an anaerobic flesh-eater. Proc. Natl. Acad. Sci. USA 99, 996–1001.
Nelson, K. E., Paulsen, I. T., Heidelberg, J. F., and Fraser, C. M. (2000) Status of genome projects for nonpathogenic bacteria and archaea. Nat. Biotechnol. 18, 1049–1054.
Pizza, M., Scarlato, V., Masignani, V., et al. (2000) Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing. Science 287, 1816–1820.
Hensel, M., Shea, J. E., Gleeson, C., Jones, M. D., Dalton, E., and Holden, D. W. (1995) Simultaneous identification of bacterial virulence genes by negative selection. Science 269, 400–403.
Hong, P. C., Tsolis, R. M., and Ficht, T. A. (2000) Identification of genes required for chronic persistence of Brucella abortus in mice. Infect. Immun. 68, 4102–4107.
Tsolis, R. M., Townsend, S. M., Miao, E. A., et al. (1999) Identification of a putative Salmonella enterica serotype typhimurium host range factor with homology to IpaH and YopM by signature-tagged mutagenesis. Infect. Immun. 67, 6385–6393.
Hutchison, C. A., Peterson, S. N., Gill, S. R., et al. (1999) Global transposon mutagenesis and a minimal Mycoplasma genome. Science 286, 2165–2169.
Wei, Y., Lee, J. M., Richmond, C., Blattner, F. R., Rafalski, J. A., and LaRossa, R. A. (2001) High-density microarray-mediated gene expression profiling of Escherichia coli. J. Bacteriol. 183, 545–556.
Wilson, M., DeRisi, J., Kristensen, H. H., et al. (1999) Exploring drug-induced alterations in gene expression in Mycobacterium tuberculosis by microarray hybridization. Proc. Natl. Acad. Sci. USA 96, 12,833–12,838.
Israel, D. A., Salama, N., Krishna, U., et al. (2001) Helicobacter pylori genetic diversity within the gastric niche of a single human host. Proc. Natl. Acad. Sci. USA 98, 14,625–14,630.
Dziejman, M., Balon, E., Boyd, D., Fraser, C. M., Heidelberg, J. F., and Mekalanos, J. J. (2002) Comparative genomic analysis of Vibrio cholerae: genes that correlate with cholera endemic and pandemic disease. Proc. Natl. Acad. Sci. USA 99, 1556–1561.
Sassetti, C. M., Boyd, D. H., and Rubin, E. J. (2001) Comprehensive identification of conditionally essential genes in mycobacteria. Proc. Natl. Acad. Sci. USA 98, 12,712–12,717.
Perna, N. T., Plunkett, G., 3rd, Burland, V., et al. (2001) Genome sequence of enterohaemorrhagic Escherichia coli O157:H7. Nature 409, 529–533.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Humana Press Inc., Totowa, NJ
About this chapter
Cite this chapter
Seshadri, R., Read, T.D., Nierman, W.C., Paulsen, I.T. (2005). Genomic Efforts With Biodefense Pathogens. In: Lindler, L.E., Lebeda, F.J., Korch, G.W. (eds) Biological Weapons Defense. Infectious Disease. Humana Press. https://doi.org/10.1385/1-59259-764-5:417
Download citation
DOI: https://doi.org/10.1385/1-59259-764-5:417
Publisher Name: Humana Press
Print ISBN: 978-1-58829-184-4
Online ISBN: 978-1-59259-764-2
eBook Packages: MedicineMedicine (R0)